메뉴 건너뛰기




Volumn 18, Issue 5, 2003, Pages 400-405

Beta-blockade in chronic heart failure: Does it work in everyone?

Author keywords

blockade; Age; Economics; Gender; Heart failure; Race

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CARVEDILOL; CATECHOLAMINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; INOTROPIC AGENT; METOPROLOL; PLACEBO; PROPRANOLOL; TIMOLOL; VASODILATOR AGENT;

EID: 0141564655     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200309000-00013     Document Type: Review
Times cited : (2)

References (55)
  • 1
    • 0026695294 scopus 로고
    • The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
    • Packer M: The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992, 20:248.
    • (1992) J Am Coll Cardiol , vol.20 , pp. 248
    • Packer, M.1
  • 2
    • 0021144839 scopus 로고
    • Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without heart failure
    • Swedberg K, Viquerat C, Rouleau JL, et al.: Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without heart failure. Am J Cardiol 1984, 54:783-786.
    • (1984) Am J Cardiol , vol.54 , pp. 783-786
    • Swedberg, K.1    Viquerat, C.2    Rouleau, J.L.3
  • 3
    • 0022492202 scopus 로고
    • Norepinephrine spillover to plasma in patients with chronic congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity
    • Hasking GJ, Esler MD, Jennings GL, et al.: Norepinephrine spillover to plasma in patients with chronic congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986, 73:615-621.
    • (1986) Circulation , vol.73 , pp. 615-621
    • Hasking, G.J.1    Esler, M.D.2    Jennings, G.L.3
  • 4
    • 0028865418 scopus 로고
    • Adverse consequences of high sympathetic nervous activity in the failing human heart
    • Kaye DM, Lefkovits J, Jennings GL, et al.: Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995, 26:1257-1263.
    • (1995) J Am Coll Cardiol , vol.26 , pp. 1257-1263
    • Kaye, D.M.1    Lefkovits, J.2    Jennings, G.L.3
  • 5
    • 0021194420 scopus 로고
    • Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
    • Cohn JN, Levine TB, Olivari MT, et al.: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984, 311:819-823.
    • (1984) N Engl J Med , vol.311 , pp. 819-823
    • Cohn, J.N.1    Levine, T.B.2    Olivari, M.T.3
  • 6
    • 0034642975 scopus 로고    scopus 로고
    • Beta-adrenergic blocking agents in heart failure: Benefits of vasodilating and non-vasodilating agents according to patients' characteristics: A meta-analysis of clinical trials
    • Boner S, Agusti A, Arnau JM, et al.: Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials. Arch Intern Med 2000, 160:621.
    • (2000) Arch Intern Med , vol.160 , pp. 621
    • Boner, S.1    Agusti, A.2    Arnau, J.M.3
  • 7
    • 0035799381 scopus 로고    scopus 로고
    • Beta-blockers in congestive heart failure. A Bayesian meta-analysis
    • Brophy JM, Joseph L, Rouleau Jl.: Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med 2001, 134:550.
    • (2001) Ann Intern Med , vol.134 , pp. 550
    • Brophy, J.M.1    Joseph, L.2    Rouleau, J.L.3
  • 8
    • 0034620523 scopus 로고    scopus 로고
    • Beta-adrenergic receptor blockade in chronic heart failure
    • Bristow MR: Beta-adrenergic receptor blockade in chronic heart failure. Circulation 2000, 101:558.
    • (2000) Circulation , vol.101 , pp. 558
    • Bristow, M.R.1
  • 9
    • 13544261892 scopus 로고
    • Chronic β-blocker-vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placebo
    • Gilbert EM, Anderson JL, Deitchman D: Chronic β-blocker-vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placebo. Am J Med 1990, 88:223.
    • (1990) Am J Med , vol.88 , pp. 223
    • Gilbert, E.M.1    Anderson, J.L.2    Deitchman, D.3
  • 10
    • 0030049090 scopus 로고    scopus 로고
    • Early reduction of neurohumoral factors plays a key role in mediating the efficacy of β-blocker therapy for congestive heart failure
    • Yoshikawa T, Handa S, Anzai T, et al.: Early reduction of neurohumoral factors plays a key role in mediating the efficacy of β-blocker therapy for congestive heart failure. Am Heart J 1996, 131:329.
    • (1996) Am Heart J , vol.131 , pp. 329
    • Yoshikawa, T.1    Handa, S.2    Anzai, T.3
  • 11
    • 0025966688 scopus 로고
    • Effects of bucindolol on neurohormonal activation in congestive heart failure
    • Eichhorn EJ, McGhie AL, Bedotto JB, et al.: Effects of bucindolol on neurohormonal activation in congestive heart failure. Am J Cardiol 1991, 67:67.
    • (1991) Am J Cardiol , vol.67 , pp. 67
    • Eichhorn, E.J.1    McGhie, A.L.2    Bedotto, J.B.3
  • 12
    • 0034142256 scopus 로고    scopus 로고
    • Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy. The Randomized Evaluation of Strategies for Left Ventricular Dysfunction pilot study
    • The RESOLVD Investigators: Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy. The Randomized Evaluation of Strategies for Left Ventricular Dysfunction pilot study. Circulation 2000, 101:378.
    • (2000) Circulation , vol.101 , pp. 378
  • 13
    • 0030023824 scopus 로고    scopus 로고
    • Changes in plasma endothelin-1 levels reflect clinical response to β-blockade in chronic heart failure
    • Krum H, Gu A, Wilshire-Clement M, et al.: Changes in plasma endothelin-1 levels reflect clinical response to β-blockade in chronic heart failure. Am Heart J 1996, 131:337.
    • (1996) Am Heart J , vol.131 , pp. 337
    • Krum, H.1    Gu, A.2    Wilshire-Clement, M.3
  • 14
    • 0030997947 scopus 로고    scopus 로고
    • Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease
    • Doughty RN, Whalley GA, Gamble G, et al.: Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol 1997, 29:1060.
    • (1997) J Am Coll Cardiol , vol.29 , pp. 1060
    • Doughty, R.N.1    Whalley, G.A.2    Gamble, G.3
  • 15
    • 0033662090 scopus 로고    scopus 로고
    • Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure
    • Groenning BA, Nilsson JC, Sondergaard L, et al.: Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol 2000, 36:2072.
    • (2000) J Am Coll Cardiol , vol.36 , pp. 2072
    • Groenning, B.A.1    Nilsson, J.C.2    Sondergaard, L.3
  • 16
    • 0033561146 scopus 로고    scopus 로고
    • Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure
    • Lowes BD, Gill EA, Abraham WT, et al.: Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol 1999, 83:1201.
    • (1999) Am J Cardiol , vol.83 , pp. 1201
    • Lowes, B.D.1    Gill, E.A.2    Abraham, W.T.3
  • 17
    • 0016701034 scopus 로고
    • Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy
    • Waagstein F, Hjalmarson A, Varnauskas E, et al.: Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975, 37:1022.
    • (1975) Br Heart J , vol.37 , pp. 1022
    • Waagstein, F.1    Hjalmarson, A.2    Varnauskas, E.3
  • 18
    • 0027135308 scopus 로고
    • Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
    • Waagstein F, Bristow MR, Swedberg K, et al.: Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993, 342:1441.
    • (1993) Lancet , vol.342 , pp. 1441
    • Waagstein, F.1    Bristow, M.R.2    Swedberg, K.3
  • 19
    • 0033549290 scopus 로고    scopus 로고
    • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
    • MERIT-HF Study Group: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999, 353:2001.
    • (1999) Lancet , vol.353 , pp. 2001
  • 20
    • 0034104565 scopus 로고    scopus 로고
    • Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF)
    • MERIT-HF Study Group
    • Hjalmarson A, Goldstein S, Fagerberg B, et al.: Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 2000, 283:1295.
    • (2000) JAMA , vol.283 , pp. 1295
    • Hjalmarson, A.1    Goldstein, S.2    Fagerberg, B.3
  • 21
    • 0028092116 scopus 로고
    • A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS)
    • CIBIS Investigators and Committees: A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994, 90:1765.
    • (1994) Circulation , vol.90 , pp. 1765
  • 22
    • 0030819145 scopus 로고    scopus 로고
    • Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency Bisoprolol study (CIBIS)
    • Lechat P, Escolano S, Golmard JL, et al.: Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency Bisoprolol study (CIBIS). Circulation 1997, 96:2197.
    • (1997) Circulation , vol.96 , pp. 2197
    • Lechat, P.1    Escolano, S.2    Golmard, J.L.3
  • 23
    • 0033514046 scopus 로고    scopus 로고
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
    • CIBIS-II Investigators and Committees: The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999, 353:9.
    • (1999) Lancet , vol.353 , pp. 9
  • 24
    • 0036481456 scopus 로고    scopus 로고
    • Bisoprolol for the treatment of chronic heart failure: A meta-analysis on individual data of two placebo-controlled studies-CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study
    • Leizorovicz A, Lechat P, Cucherat M, et al.: Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies-CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study. Am Heart J 2002, 143:301.
    • (2002) Am Heart J , vol.143 , pp. 301
    • Leizorovicz, A.1    Lechat, P.2    Cucherat, M.3
  • 25
    • 10544251442 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise
    • Packer M, Colucci WS, Sackner-Bernstein JD, et al.: Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. Circulation 1996, 94:2793.
    • (1996) Circulation , vol.94 , pp. 2793
    • Packer, M.1    Colucci, W.S.2    Sackner-Bernstein, J.D.3
  • 26
    • 10544231452 scopus 로고    scopus 로고
    • Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure
    • US Carvedilol Heart Failure Study Group
    • Colucci WS, Packer M, Bristow MR, et al.: Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation 1996, 94:2800.
    • (1996) Circulation , vol.94 , pp. 2800
    • Colucci, W.S.1    Packer, M.2    Bristow, M.R.3
  • 27
    • 0028209224 scopus 로고
    • Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy
    • Bucindolol Investigators
    • Bristow MR, O'Connell JB, Gilbert EM, et al.: Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators. Circulation 1994, 89:1632.
    • (1994) Circulation , vol.89 , pp. 1632
    • Bristow, M.R.1    O'Connell, J.B.2    Gilbert, E.M.3
  • 28
    • 0029937949 scopus 로고    scopus 로고
    • The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
    • for the US Carvedilol Heart Failure Study Group
    • Packer M, Bristow MR, Cohn JN, et al.: for the US Carvedilol Heart Failure Study Group: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996, 334:1349.
    • (1996) N Engl J Med , vol.334 , pp. 1349
    • Packer, M.1    Bristow, M.R.2    Cohn, J.N.3
  • 29
    • 0035978763 scopus 로고    scopus 로고
    • Effect of carvedilol on survival in severe chronic heart failure
    • Packer M, Coats AJ, Fowler MB, et al.: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001, 344:1651.
    • (2001) N Engl J Med , vol.344 , pp. 1651
    • Packer, M.1    Coats, A.J.2    Fowler, M.B.3
  • 30
    • 0035978801 scopus 로고    scopus 로고
    • A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
    • The Beta-Blocker Evaluation of Survival Trial (BEST) Investigators: A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 2001, 344:1659.
    • (2001) N Engl J Med , vol.344 , pp. 1659
  • 31
    • 0037138797 scopus 로고    scopus 로고
    • Beta-blocker therapy in heart failure: Scientific review
    • Foody JM, Farrell MH, Krumholz HM: Beta-blocker therapy in heart failure: scientific review. JAMA 2002, 287:883.
    • (2002) JAMA , vol.287 , pp. 883
    • Foody, J.M.1    Farrell, M.H.2    Krumholz, H.M.3
  • 32
    • 0035040375 scopus 로고    scopus 로고
    • Influence of carvedilol on hospitalizations in heart failure: Incidence, resource utilization and costs
    • U.S. Carvedilol Heart Failure Study Group
    • Fowler MB, Vera-Llonch M, Oster G, et al.: Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group. J Am Coll Cardiol 2001, 37:1692.
    • (2001) J Am Coll Cardiol , vol.37 , pp. 1692
    • Fowler, M.B.1    Vera-Llonch, M.2    Oster, G.3
  • 33
    • 0034814619 scopus 로고    scopus 로고
    • Metoprolol controlled release/extended release in patients with severe heart failure. Analysis of the experience in the MERIT-HF study
    • Goldstein S, Fagerberg B, Hjalmarson A, et al.: Metoprolol controlled release/extended release in patients with severe heart failure. Analysis of the experience in the MERIT-HF study. J Am Coll Cardiol 2001, 38:932.
    • (2001) J Am Coll Cardiol , vol.38 , pp. 932
    • Goldstein, S.1    Fagerberg, B.2    Hjalmarson, A.3
  • 34
    • 0035810547 scopus 로고    scopus 로고
    • Effect of carvedilol on outcome after myocardial infarction in patients with leff-ventricular dysfunction: The CAPRICORN randomized trial
    • Dargie HJ: Effect of carvedilol on outcome after myocardial infarction in patients with leff-ventricular dysfunction: the CAPRICORN randomized trial. Lancet 2001, 357:1385-1390.
    • (2001) Lancet , vol.357 , pp. 1385-1390
    • Dargie, H.J.1
  • 35
    • 0036676583 scopus 로고    scopus 로고
    • The effects of Carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
    • Otterstad JE, Ford I: The effects of Carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials? Eur J Heart Fail 2002, 4:501-506.
    • (2002) Eur J Heart Fail , vol.4 , pp. 501-506
    • Otterstad, J.E.1    Ford, I.2
  • 36
    • 0038329022 scopus 로고    scopus 로고
    • The Incomplete Bucindolol Evaluation in Acute Myocardial Infarction Trial (BEAT)
    • Torp-Pederson C, Kober L, Ball S, et al.: The Incomplete Bucindolol Evaluation in Acute Myocardial Infarction Trial (BEAT). Eur J Heart Fail 2002, 4:495-499.
    • (2002) Eur J Heart Fail , vol.4 , pp. 495-499
    • Torp-Pederson, C.1    Kober, L.2    Ball, S.3
  • 37
    • 0033558687 scopus 로고    scopus 로고
    • Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A post hoc analysis of the Studies of Left Ventricular Dysfunction
    • Exner DV, Dries DL, Waclawiw MA, et al.: Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A post hoc analysis of the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1999, 33:916.
    • (1999) J Am Coll Cardiol , vol.33 , pp. 916
    • Exner, D.V.1    Dries, D.L.2    Waclawiw, M.A.3
  • 38
    • 0034911718 scopus 로고    scopus 로고
    • The Carvedilol and ACE-inhibitor Remodeling Mild Heart Failure Evaluation Trial (CARMEN): Rational & Design
    • Remme WJ, CARMEN steering committee & investigators: The Carvedilol and ACE-inhibitor Remodeling Mild Heart Failure Evaluation Trial (CARMEN): Rational & Design. Cardiovasc Drugs Ther 2001, 15:69-77.
    • (2001) Cardiovasc Drugs Ther , vol.15 , pp. 69-77
    • Remme, W.J.1
  • 39
    • 0035936485 scopus 로고    scopus 로고
    • Sex differences in the prognosis of congestive heart failure: Results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II)
    • Simon T, Mary-Krause M, Funck-Brentano C, et al.: Sex differences in the prognosis of congestive heart failure: Results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation 2001, 103:375-380.
    • (2001) Circulation , vol.103 , pp. 375-380
    • Simon, T.1    Mary-Krause, M.2    Funck-Brentano, C.3
  • 40
    • 0037007046 scopus 로고    scopus 로고
    • Metoprolol CR/XL in female patients with heart failure: Analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)
    • Ghali JK, Pina IL, Gottlieb SS, et al.: Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation 2002, 105:1585.
    • (2002) Circulation , vol.105 , pp. 1585
    • Ghali, J.K.1    Pina, I.L.2    Gottlieb, S.S.3
  • 41
    • 0035799754 scopus 로고    scopus 로고
    • Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure
    • Yancy CW, Fowler MB, Colucci WS, et al.: Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med 2001, 344:1358.
    • (2001) N Engl J Med , vol.344 , pp. 1358
    • Yancy, C.W.1    Fowler, M.B.2    Colucci, W.S.3
  • 42
    • 0036195111 scopus 로고    scopus 로고
    • Role of race in the pharmacotherapy of heart failure
    • Kalus JS, Nappi JM: Role of race in the pharmacotherapy of heart failure. Ann Pharmacother 2002, 36:471-478.
    • (2002) Ann Pharmacother , vol.36 , pp. 471-478
    • Kalus, J.S.1    Nappi, J.M.2
  • 43
    • 0036918486 scopus 로고    scopus 로고
    • The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure
    • Sin DD, McAlister FA: The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure. Am J Med 2002, 113:650-656.
    • (2002) Am J Med , vol.113 , pp. 650-656
    • Sin, D.D.1    McAlister, F.A.2
  • 44
    • 0036607936 scopus 로고    scopus 로고
    • Comparison of the beta-blocker Bucindolol in younger versus older patients with heart failure
    • Aranda JM, Krause-Steinrauf HJ, Greenberg BH, et al.: Comparison of the beta-blocker Bucindolol in younger versus older patients with heart failure. Am J Cardiol 2002, 89:1322-1326.
    • (2002) Am J Cardiol , vol.89 , pp. 1322-1326
    • Aranda, J.M.1    Krause-Steinrauf, H.J.2    Greenberg, B.H.3
  • 45
    • 0030853984 scopus 로고    scopus 로고
    • Effects of Propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction >40% treated with diuretics plus ACE-inhibitor
    • Aronow WS, Ahn C, Kronzon I: Effects of Propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction >40% treated with diuretics plus ACE-inhibitor. Am J Cardiol 1997, 80:207-209.
    • (1997) Am J Cardiol , vol.80 , pp. 207-209
    • Aronow, W.S.1    Ahn, C.2    Kronzon, I.3
  • 46
    • 0036899667 scopus 로고    scopus 로고
    • Beta blockers in older persons with heart failure: Tolerability and impact on quality of life
    • Baxter AJ, Spensley A, Hildreth A, et al.: Beta blockers in older persons with heart failure: tolerability and impact on quality of life. Heart 2002, 88:611-614.
    • (2002) Heart , vol.88 , pp. 611-614
    • Baxter, A.J.1    Spensley, A.2    Hildreth, A.3
  • 47
    • 0036518292 scopus 로고    scopus 로고
    • Effects of Carvedilol on the hemodynamics and its tolerance in elderly patients
    • Asai T, Kuzuya M, Koike A, et al.: Effects of Carvedilol on the hemodynamics and its tolerance in elderly patients. Nippon Ronen Igakkai Zasshi 2002, 39:187-192.
    • (2002) Nippon Ronen Igakkai Zasshi , vol.39 , pp. 187-192
    • Asai, T.1    Kuzuya, M.2    Koike, A.3
  • 48
    • 0036383438 scopus 로고    scopus 로고
    • Cost-effectiveness of beta-blocker treatment in heart failure
    • Gilbert EM: Cost-effectiveness of beta-blocker treatment in heart failure. Rev Cardiovasc Med 2002, 3(suppl 3):S42-S47.
    • (2002) Rev Cardiovasc Med , vol.3 , Issue.3 SUPPL.
    • Gilbert, E.M.1
  • 49
    • 0035821327 scopus 로고    scopus 로고
    • Economic impact of beta blockade in heart failure
    • Gregory D, Udelson JE, Konstam MA: Economic impact of beta blockade in heart failure. Am J Med 2001, 110(suppl 7A):74S-80S.
    • (2001) Am J Med , vol.110 , Issue.SUPPL. 7A
    • Gregory, D.1    Udelson, J.E.2    Konstam, M.A.3
  • 50
    • 0036238135 scopus 로고    scopus 로고
    • Cost and cost-effectiveness studies in heart failure research
    • Weintraub WS, Cole J, Tooley JF: Cost and cost-effectiveness studies in heart failure research. Am Heart J 2002, 143:565-576.
    • (2002) Am Heart J , vol.143 , pp. 565-576
    • Weintraub, W.S.1    Cole, J.2    Tooley, J.F.3
  • 51
    • 0034904188 scopus 로고    scopus 로고
    • Reduced costs with Bisoprolol treatment for heart failure: An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)
    • CIBIS-II Investigators and Health Economic Group: Reduced costs with Bisoprolol treatment for heart failure: an economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II). Eur Heart J 2001, 22:1021-1031.
    • (2001) Eur Heart J , vol.22 , pp. 1021-1031
  • 52
    • 0035040375 scopus 로고    scopus 로고
    • Influence of Carvedilol on hospitalization in heart failure: Incidence, resource utilization and costs
    • U.S. Carvedilol Heart Failure Study Group
    • Fowler MB: Influence of Carvedilol on hospitalization in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group. J Am Coll Cardiol 2001, 37:1692-1699.
    • (2001) J Am Coll Cardiol , vol.37 , pp. 1692-1699
    • Fowler, M.B.1
  • 53
    • 0034923394 scopus 로고    scopus 로고
    • Cost-effectiveness results from the US Carvedilol Heart Failure Trials Program
    • Vera-Llonch M, Menzin J, Richner RE, et al.: Cost-effectiveness results from the US Carvedilol Heart Failure Trials Program. Ann Pharmacother 2001, 35:846-851.
    • (2001) Ann Pharmacother , vol.35 , pp. 846-851
    • Vera-Llonch, M.1    Menzin, J.2    Richner, R.E.3
  • 54
    • 0033028999 scopus 로고    scopus 로고
    • Cost effectiveness of Carvedilol for heart failure
    • Delea TE, Vera-Llonch M, Richner RE, et al.: Cost effectiveness of Carvedilol for heart failure. Am J Cardiol 1999, 83:890-896.
    • (1999) Am J Cardiol , vol.83 , pp. 890-896
    • Delea, T.E.1    Vera-Llonch, M.2    Richner, R.E.3
  • 55
    • 0034870055 scopus 로고    scopus 로고
    • Cost-effectiveness of beta-blocker therapy with Metoprolol or with Carvedilol for treatment of heart failure in Canada
    • Levy AR, Briggs AH, Demers C, et al.: Cost-effectiveness of beta-blocker therapy with Metoprolol or with Carvedilol for treatment of heart failure in Canada. Am Heart J 2001, 142:537-543.
    • (2001) Am Heart J , vol.142 , pp. 537-543
    • Levy, A.R.1    Briggs, A.H.2    Demers, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.